Tonix Pharmaceuticals Holdin

Biotech Stocks Healthcare Stocks

$12.25

-0.25 (-2.00%)

As of Aug 15, 2:09 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +232.6% upside

Low Target $28.14

Average Target $40.74

High Target $50.62

Current Price $12.25

Current
$12.25

Target
$40.74

$28.14 $40.74 avg $50.62

Scenario Analysis

Bear Case

$28.14

129.7%

Low target

Base Case

$40.74

+232.6%

Avg target

Bull Case

$50.62

+313.2%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$69.97

-82.5% from high

52-Week Low

$9.40

+30.3% from low

Target vs 52W High

$40.74

-41.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%